AIMBLE
Latest round
- Seed
Last raised
- Jul 2021
Total raised
- $0.3M
Investors
- 3
About AIMBLE
AIMBLE is an innovative company specializing in AI-driven drug discovery, utilizing advanced technologies for efficient and precise identification of novel drug candidates.AIMBLE, founded in 2020, is based in Seoul, South Korea, and focuses on AI-driven drug discovery. The company has undergone no significant pivots in its business strategy since inception.AIMBLE specializes in an AI-driven drug discovery platform known as AIMBLE CADD, which integrates advanced technologies such as molecular docking, artificial intelligence, quantum calculations, and molecular dynamics simulations. This platform enables the identification and design of novel drug candidates with a focus on efficiency and precision. Additionally, AIMBLE operates the AIMBLE Synthesis Lab, facilitating the rapid construction of chemical compounds specifically designed through its CADD platform, allowing for expedited in-vitro and in-vivo experiments.AIMBLE generates revenue through a combination of B2B partnerships and direct service offerings. Clients, primarily from the pharmaceutical and biotech industries, collaborate with AIMBLE to leverage its CADD platform and synthesis services, involving contractual agreements for access to its technology. Revenue is structured around service fees for drug design projects and synthesis services, as well as potential licensing agreements for proprietary technologies developed through the AIMBLE platform. The company aims to develop new products that will streamline drug discovery processes and enter new markets, particularly targeting expansions in North America and Europe by the end of 2023.
Who invested in AIMBLE
3 investors across 3 rounds
See all investors in AIMBLE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AIMBLE
Who invested in AIMBLE?
AIMBLE has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AIMBLE raised?
AIMBLE has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did AIMBLE last raise money?
AIMBLE's most recent round on record is a Seed, in Jul 2021.
What does AIMBLE do?
AIMBLE is an innovative company specializing in AI-driven drug discovery, utilizing advanced technologies for efficient and precise identification of novel drug candidates.
Where is AIMBLE headquartered?
AIMBLE is headquartered in Seoul, South Korea.
Which VCs invest in companies like AIMBLE?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at AIMBLE's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like AIMBLE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.